Cryo-Cell International issues dividends to shareholders from excess cash Cryo-Cell International generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, ...
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced ...
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”, “Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that the Company ...
(RTTNews) - Private cord blood bank Cryo-Cell International, Inc. (CCEL) announced Monday that its Board of Directors has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the ...
Maxim lowered the firm’s price target on Cryo-Cell (CCEL) to $8.50 from $9 and keeps a Buy rating on the shares. The company’s Q4 adjusted EBITDA miss was likely due to higher litigation expenses, ...
Counsel at Shumaker Loop & Kendrick and Hogan Lovells on Tuesday removed a consumer class action against Cryo-Cell to Florida Southern District Court. The suit arises from Cryo-Cell's 'blood banking' ...
This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange ...
Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results